Trials / Completed
CompletedNCT04009707
Comparison of 2 Tests to Diagnose Cognitive Dysfunctions in Alcohol Disease
Comparison of 2 Tests for Screening for Cognitive Disorders (MoCA / BEARNI)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The objective of this study is therefore to compare the results obtained with these two screening tests, using as gold standard the results obtained by the battery of neuropsychological reference tests.
Detailed description
Recently, a new screening test for cognitive disorders was specifically developed for patients with UAS: BEARNI (Brief Evaluation of Alcohol-Related Neuropsychological Impairments). Since the BEARNI is presented as the reference test, the investigators have systematically proposed it to hospitalized patients, in combination with the usual check-up. In practice, at admission, patients were therefore given two screening tests, the MoCA and the BEARNI. In the event of an anomaly in at least one of these tests, a battery of confirmatory neuropsychological tests was performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | MoCA (Montreal Cognitive Assessment) test | the MoCA questionnaire is used to assess cognitive disorders |
| OTHER | BEARNI (Brief Evaluation of Alcohol Related Neuropsychological Impairment) Test | This questionnaire is used to assess cognitive disorders |
Timeline
- Start date
- 2017-11-02
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2019-07-05
- Last updated
- 2025-12-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04009707. Inclusion in this directory is not an endorsement.